Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Non Operating Income (2009 - 2021)

Grifols' (GIFLF) quarterly Non Operating Income came in at $85.6 million in Q4 2021, up 0.82% on a YoY basis from $84.9 million in Q4 2020, and up 0.82% quarter-over-quarter from $84.9 million in Q4 2020.

Analysis

Grifols (GIFLF) Non Operating Income (2009 - 2021) Analysis & Trends

Grifols (GIFLF) has reported Non Operating Income for 10 consecutive years, with $85.6 million the latest figure, recorded in Q4 2021.

  • For the quarter ending Q4 2021, Non Operating Income rose 0.82% year-over-year to $85.6 million; the trailing twelve-month figure through Dec 2021 stood at $303.7 million (up 1.17% YoY), and the FY2021 full-year result was $85.6 million, up 0.82% from the prior year.
  • Non Operating Income climbed to $85.6 million in Q4 2021 per GIFLF's latest filing, from $84.9 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $85.6 million in Q4 2021 and bottomed at $71.0 million in Q4 2019.
  • Historically, Non Operating Income has averaged $80.5 million across 3 years, with a median of $84.9 million in 2020.
  • The sharpest annual moves came in 2020 and 2021: Non Operating Income gained 19.72% in 2020, then grew 0.82% in 2021.
  • Over 3 years, Non Operating Income stood at $71.0 million in 2019, then increased by 19.72% to $84.9 million in 2020, then climbed by 0.82% to $85.6 million in 2021.
  • According to Business Quant data, Non Operating Income over the past three periods registered $85.6 million, $84.9 million, and $71.0 million for Q4 2021, Q4 2020, and Q4 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -73.00 Mn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 387.00 Mn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 234.30 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -53.64 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 85.64 Mn
Dec 31, 2020 84.94 Mn
Dec 31, 2019 70.95 Mn
Dec 31, 2015 62.20 Mn
Dec 31, 2014 82.14 Mn
Dec 31, 2013 59.45 Mn
Dec 31, 2012 3.98 Mn
Dec 31, 2011 6.68 Mn
Dec 31, 2010 452,204.83
Dec 31, 2009 1.16 Mn